You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Parathyroid disorders

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

  • Technology appraisal guidance
  • Reference number: TA117
  • Published:  24 January 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • Appendix A. Appraisal Committee members and NICE project team
  • Appendix B. Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance

7 Related NICE guidance

  • Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. NICE technology appraisal guidance 48 (2002).

  • Chronic kidney disease: Early identification and management of chronic kidney disease in adults in primary and secondary care. NICE clinical guideline 73 (2008).


Next page 8 Review of guidance Previous page 6 Recommendations for further research